November 12, 2025 | 10:16 AM ET
**Top Contributors and Detractors in Q3 2025**
Wasatch Global Investors recently released commentary on the performance of the Wasatch Ultra Growth Fund for the third quarter of 2025. Among the top contributors to the fund’s strong performance were **Esperion Therapeutics, Inc.** and **C4 Therapeutics, Inc.** Another notable contributor was **SiTime Corp.**, a company specializing in silicon timing chips used across a wide range of electronic devices.
On the other hand, the greatest detractor from the fund’s performance during the quarter was **Monday.com Ltd.**
**Benchmark Performance**
The benchmark Russell 2000® Growth Index rose by 12.19% in Q3 2025. The Wasatch Ultra Growth Fund trailed this benchmark during the same period, as detailed in the firm’s Q3 commentary.
—
### About Wasatch Global Investors
Wasatch Global Investors is a 100% employee-owned investment manager founded in 1975 and headquartered in Salt Lake City, Utah. Named after the nearby Wasatch Mountain Range, the firm leverages extensive experience in U.S. and international micro-, small-, and mid-cap investing.
The company prides itself on a culture that emphasizes collaboration, excellence, and intellectual curiosity. Wasatch Global Investors is registered with the Securities and Exchange Commission under the Investment Advisers Act of 1940.
—
**Recommended for You:**
[Related articles or investment insights could be linked here.]
—
*Disclaimer: This article is based on information provided by Wasatch Global Investors and is for informational purposes only. Investment decisions should be made based on individual objectives and professional advice.*
https://seekingalpha.com/article/4842452-wasatch-ultra-growth-fund-q3-2025-top-contributors-and-detractors?source=feed_all_articles